Paramount, states discuss CNN monitoring and film release pledge, sources say

• Independent content monitoring of CNN is one of the key terms being discussed as part of the settlement
• Paramount is considering commitments on the number of theatrical releases it will maintain
• The settlement between Paramount and the states over the Warner Bros acquisition could be finalized within days

Summary

Key Development: Paramount and multiple U.S. states are in final negotiations over conditions related to Paramount's acquisition of Warner Bros, with a settlement expected as soon as this weekend or Monday (September 21, 2026).

Main Terms Under Discussion:

• Independent content monitoring of CNN: The agreement would involve third-party oversight of CNN's content operations
• Theatrical release commitments: Paramount would pledge to maintain a minimum number of theatrical film releases

Companies Involved:

• Paramount (acquirer)
• Warner Bros (acquisition target, which owns CNN)
• Multiple U.S. states (regulatory parties)

Market Implications:

This settlement would represent a significant step toward clearing regulatory hurdles for the Paramount-Warner Bros merger, a major consolidation in the media and entertainment industry. The requirement for CNN monitoring suggests state regulators have concerns about content practices and editorial independence post-merger. The theatrical release commitment indicates concerns about maintaining traditional cinema distribution channels amid streaming consolidation.

The rapid timeline—with settlement potentially coming within days—suggests both parties are eager to finalize the deal. These concessions appear designed to address antitrust and public interest concerns while allowing the acquisition to proceed.

Context: This merger would combine two major Hollywood studios and bring CNN under Paramount's corporate umbrella, creating a significant media conglomerate with substantial influence across film, television, and news sectors.

Status: Negotiations ongoing; settlement imminent pending final agreement on monitoring and release terms.